Galip Can Uyar: Access to Healthcare Can Be a Powerful Determinant of Patient Outcomes
Galip Can Uyar, Medical Doctor at Etlik City Hospital, shared a post on X:
“Access to healthcare can be a powerful determinant of patient outcomes.
This large cohort study published in JCO Global Oncology investigates the impact of treatment funding source on survival in patients with bladder cancer.
Among 6,217 patients:
5-year OS in privately funded patients: 68.5%
5-year OS in publicly funded patients: 53.7%
The survival gap persisted independently of age, TNM stage, or education level. Funding source remained an independent predictor of overall survival (aHR: 1.41; p < .001).
These findings carry broader implications beyond Brazil: Structural disparities in healthcare access can decisively shape clinical outcomes. Yet these gaps are not inevitable — with early diagnosis, equitable resource allocation, and policy reform, they can be closed.”
Title: Survival According to Source of Treatment Funding in Bladder Cancer: Analysis of a Large Public Database From São Paulo, Brazil
Authors: Fernando C. Maluf, Cintia S. K. S. de Oliveira, Patricia K. Ziegelmann,
More posts featuring Galip Can Uyar on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023